Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.01 | uM | 7 | 312.50 | 133.67 | 339.00 | 277.50 | 1.2216 | 1.4184 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 312.50 | 133.67 | 177.00 | 277.50 | 0.6378 | 0.3053 |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 312.50 | 133.67 | 387.00 | 277.50 | 1.3946 | 1.7422 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 312.50 | 133.67 | 374.00 | 277.50 | 1.3477 | 1.6547 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 312.50 | 133.67 | 340.00 | 277.50 | 1.2252 | 1.4251 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 319.00 | 277.50 | 1.1495 | 1.2828 | |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 312.50 | 133.67 | 387.00 | 277.50 | 1.3946 | 1.7422 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 306.00 | 277.50 | 1.1027 | 1.1944 |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 312.50 | 133.67 | 325.00 | 277.50 | 1.1712 | 1.3235 |
| BT-20 | Erlotinib | 1 | uM | 7 | 312.50 | 133.67 | 312.00 | 277.50 | 1.1243 | 1.2352 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 312.50 | 133.67 | 170.00 | 277.50 | 0.6126 | 0.2563 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 312.50 | 133.67 | 350.00 | 277.50 | 1.2613 | 1.4928 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 279.00 | 277.50 | 1.0054 | 1.0103 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 312.50 | 133.67 | 135.00 | 277.50 | 0.4865 | 0.0095 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 272.00 | 277.50 | 0.9802 | 0.9624 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 2.00 | 277.50 | 0.0072 | -0.9815 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 4.00 | 277.50 | 0.0144 | -0.9642 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 228.00 | 277.50 | 0.8216 | 0.6598 | |
| BT-20 | 17-AAG | 10 | uM | 7 | 312.50 | 133.67 | 109.00 | 277.50 | 0.3928 | -0.1760 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 312.50 | 133.67 | 241.00 | 277.50 | 0.8685 | 0.7495 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 292.00 | 277.50 | 1.0523 | 1.0990 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 312.50 | 133.67 | 292.00 | 277.50 | 1.0523 | 1.0990 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 295.00 | 277.50 | 1.0631 | 1.1195 | |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 312.50 | 133.67 | 299.00 | 277.50 | 1.0775 | 1.1468 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 312.50 | 133.67 | 272.00 | 277.50 | 0.9802 | 0.9624 |